Biotech and Money London 2016

WATCH

360+ ATTENDEES

100+ SPEAKERS

EVENT HIGHLIGHTS

85% DECISION MAKERS

80% LIFESCIENCE, INVESTOR & PHARMA

SILVER PARTNER

SILVER PARTNER

SILVER PARTNER

SILVER PARTNER

SILVER PARTNER

SILVER PARTNER

SILVER PARTNER

The 3rd annual Biotech and Money London event is a two-day congress providing the education, strategies and solutions life science companies need
to enable more effective funding, investment, business planning and partnering within their businesses.

At its heart is the mission to help build linkages and business opportunities for UK life science companies, capital and partners. It's where life science
meets money, investors meet deal flow and industry promotes strategic collaborations.

We are proud to bring you the third iteration of what was a highly successful congress in 2015 and 2016. With our relentless focus on quality peer-2-peer
discussion, high level networking and partnering, unique formats and a vetted, high calibre audience, we bring together the people that matter to the
future of healthcare investment and deal making.

CHANGE YOUR COMPANY'S FUNDING, INVESTMENT AND PARTNERING OUTLOOK

'Biotech and Money London is a great networking experience. I’ve had meetings with a lot of promising contacts!’

Pascal Hughes, CEO, Levrett

Andy Richards, Serial Biotechnology Entrepreneur and Business Angel

‘Money in the sector is really important. It’s one of the things that’s moving and changing dynamically. If you look at who is here at Biotech and Money London and what has been covered it was just hitting all the right nails on head.’

John Normanton, CEO, EstryX Pharma

‘One of the distinctive features of Biotech and Money is that it presents an up to date insight into the thinking of the investment community.'

Sarah Holland, Head of Europe, External Science and Partnering Strategy, Sanofi

'What I like about Biotech and Money London is that we all get the chance to present our companies during the 1-2-1 partnering sessions, allowing us to make valuable contacts.'

Peter George, CEO, Clinigen

'The CEO Forum gave me the feeling that it’s a slightly different forum where CEOs actually did have some outcome from the discussions. It’s a particularly interesting forum to discuss changes in the UK biotech and pharma sectors.'

WHO BENEFITS FROM BIOTECH AND MONEY LONDON

Introduce your company, your science and/or
technology to qualified, active life science investors
from across the UK, EU and US. From Angels and
crowdfunders, to Venture and Corporate Venture
Capital, private equity and debt finance.

LIFE SCIENCE EXECUTIVES

INVESTORS AND PHARMA

This congress will help you uncover untapped
investment and partnering opportunities in Rx, Dx,
Medtech, Devices and Digital Health. Meet a range
of Entrepreneurs and CEOs of private and publicly
listed £bn businesses.

FINANCIAL SERVICES

The congress provides an opportunity for financial
and professional services to maintain existing client
relations, generate new business opportunities and
make those all important introductions with life
science decision makers.

WHAT MAKES THE EVENT DIFFERENT

Exclusive audience

Qualified C-level only audience.

New players

Inventors, innovators and entrepreneurs.

Engaging formats

No power point.

Big on interaction.

Themed sessions

Sector spotlight thematic panels.

Group discussions

Executive level peer-to-peer debate.

1-2-1 partnering

Evaluate and arrange onsite meetings.

ETC.VENUES | 155 BISHOPSGATE | LIVERPOOL ST | LONDON | EC2M 3YD